Description: This session from the 1990 Valuation Actuary Symposium discusses three separate issues: First, the New York regulation 126 as it relates to the valuation of annuity and single premium life reserves. Second, Non-guaranteed elements opinion. Third, New Jersey Excess Interest reserve adjustment.

Description: This presentation is a panel discussion, session number 2PD, from the 2000 Valuation Actuary Symposium, held September 14-15 in Washington, DC. The panelists provide an overview of current statutory valuation issues pertaining to life and annuity products, to be covered in-depth at subsequent sessions. Topics include: new valuation table for life insurance NAIC Actuarial Guidelines [AG] for variable product guaranteed living benefits and for equity-indexed universal life [ZZZZ] amendments to the Actuarial Opinion and Memorandum Regulation [AOMR] progress on Unified Valuation System [UVS] Model Regulations on Separate Accounts Funding Group Contracts with Guarantees, and on Synthetic Guaranteed Investment Contracts [GICs] regulatory concern over liquidity and Regulation XXX mortality X factors.

Description: Intended for actuaries interested in understanding more about the Medical Loss Ratio and the impact Quality Improving Activities (QIA) and fraud reduction expenses have on the rebate calculation. This session will focus on what expenses qualifies as QIA, examples of programs from major carriers, current regulations and the differences between commercial, and Medicare, and Medicaid requirements.

Description: As the Valuation Manual continues to evolve and PBR standards for additional products are drafted and incorporated, it will become increasingly important for companies to understand how the requirements are consistent across products, as well as how they differ. The presenters will scan the life (VM-20) and annuity (VM-21, VM-22) PBR standards across the Valuation Manual to compare and contrast key requirements. Attendees will learn where common methods and techniques can be used across products and platforms.

Description: Panelists discuss many developments over the year 1991 that impact the valuation actuary. Session 1 of the 1991 Valuation Actuary Symposium.

Description: 1998 Valuation Actuary Symposium. The panelists provided background about the Unified Valuation Law model, how we got here, what's going on today in 1998, and what we can look for in the future.

Description: This presentation is an Interactive Forum, session number 20IF, from the 1999 Valuation Actuary Symposium, held September 23-24 in Los Angeles. The panelists discuss the American Academy’s Valuation Task Force and its committees working on the proposal to revise the Standard Valuation Law, referred to as the Unified Valuation Law [UVL], to update participants as to the status of the committees’ work. They provide a description of the activities currently taking place, and an update of where the revisions process stands and what the next steps are. The current system versus what is proposed are discussed, including concerns of regulators. Discussion from participants is included.

Description: This presentation is an open forum, session number 12OF, from the 2000 Valuation Actuary Symposium, held September 14-15 in Washington, DC. The National Association of Insurance Commissioners [NAIC] has proposed a requirement that certain products have risk-based capital [RBC] C-3 determined as the greater of a calculation based on fixed factors, and results of a formalized cash-flow test. The panelists provide a summary of the requirements of C-3 testing, followed by an open discussion regarding implementation issues and other questions.

Description: This session from the 1984 SOA Salt Lake City Meeting examines financial reporting for new generation life and annuity products, such as universal life, single premium deferred annuities SPDA's, and flexible premium annuities. Topics include statutory and GAAP reporting, NAIC proposed regulation for UL, management reporting and accounting treatment of rollovers and replacements.

Description: This 1980 session covers amendments to the SNL and SVL and the anticipated revision to the CSO Mortality Table. Questions discussed: 1. What changes can be expected in requirements in the1980's? 2. What changes in products design will likely emerge from these? 3. What will be the effect on future gross premium, cash value, and reserve levels? 4. Will these changes be compatible with all economic forecast scenarios? 5. Will these changes create a need for increased gross premium rates or for higher company surplus levels? 6. Should attention to solvency measures be increased? 7. Are the allowable valuation interest rates sufficiently liberal?